Facial paralysis as the only symptom of COVID-19: A prospective study

İslamoğlu, Yüce; Çelik, Burak; Kırış, Muzaffer

doi:10.1016/j.amjoto.2021.102956

Cited by 38 publications

(28 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In addition, these patients had no history of any symptoms of COVID-19 such as fever, cough, sore throat or shortness of breath in their personal history. This demonstrates a superiority in relation to seroprevalence studies carried out in asymptomatic individuals 16 . Neural ischemia, autoimmune diseases and viral inflammation of facial nerve palsy are considered responsible, but the etiology is unclear 17 .…”

Section: Resultsmentioning

confidence: 92%

See 1 more Smart Citation

Evidence for facial nerve palsy and SARS-CoV-2

Teles

Carneiro²,

Pestana³

2021

Rev Neurocienc

View full text Add to dashboard Cite

Introduction. The World Health Organization (WHO) has recognized a new strain of coronavirus, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), called Coronavirus Disease 2019 (COVID-19). The mildest and most common symptoms include fever, fatigue and cough; however, more severe cases of the disease can cause breathing difficulties, kidney and heart failure and, eventually, death. However, an increasing number of reports of neurological manifestations have emerged. Objective. Provide a comprehensive review of the neurological manifestations of SARS-CoV-2 and especially the relationship between acute facial nerve palsy and COVID-19, as well as their results in mortality and the implications that this has in clinical practice. Method. The search in seven databases (PubMed, Cochrane Library, Lilacs, Scielo, Web of Science, Scopus and Google Scholar) was carried out by two independent reviewers in search of evidence of Facial Nerve Palsy (VII) and SARS-CoV-2 . After screening, data were collected and discussed. Results. Idiopathic facial palsy is called Bell's palsy and studies have shown that facial palsy increased during the COVID-19 pandemic period. There are many reports on the relationship between COVID-19 and facial paralysis, but little real evidence of their relationship. Conclusion. It is still questionable whether these neuroimmune disorders occur directly from viral infection or as autoimmune sequelae. The pathogenesis of the disease behind this manifestation is not yet fully understood. We believe that more research should be carried out to clarify the association raised by this study.

show abstract

Section: Resultsmentioning

confidence: 92%

“…The PCR test on patients' first admission could be done to clarify the etiology. The SARS-CoV-2 antibody test to measure IgG and IgM separately can also be performed 16 .…”

Section: Resultsmentioning

confidence: 99%

Evidence for facial nerve palsy and SARS-CoV-2

Teles

Carneiro²,

Pestana³

2021

Rev Neurocienc

View full text Add to dashboard Cite

show abstract

“…2019 gab es 22 Fälle, 2020 dann 38 Fälle. In einer türkischen Studie konnten bei 24,3 % von insgesamt 41 während der Pandemie erkrankten Patienten mit Fazialisparese Antikörper gegen SARS-CoV-2 im Blut nachgewiesen werden [8]. Somit wurde die Fazialisparese womöglich durch eine Coronavirus-Infektion ausgelöst.…”

Section: Möglicherweise Ist Das Risiko Für Das Auftreten Einer Akuten Fazialisparese Durch Eine Sars-cov-2-infektion Erhöhtunclassified

Eine akute Fazialisparese als mögliche Impfkomplikation bei einer Impfung gegen SARS-CoV-2

Volk

Kuttenreich

Geitner

et al. 2021

Laryngorhinootologie

View full text Add to dashboard Cite

ZusammenfassungObwohl die akute Fazialisparese (akute Gesichtsnervenlähmung, Bell-Lähmung) als mögliche Impfkomplikation auf eine Impfung gegen SARS-CoV-2 explizit im Aufklärungsmerkblatt der Impfstoffe erwähnt wird, überwiegt aus unserer Sicht klar der Nutzen der Impfung gegenüber möglichen Risiken. Aus den bisherigen Fallbeschreibungen lässt sich allenfalls, wenn überhaupt, ein gering erhöhtes Risiko ableiten. Das Risiko einer akuten Fazialisparese ist im Zusammenhang mit vielen Impfungen beschrieben; das Risiko scheint, wenn vorhanden, kein spezifisches Risiko zu sein. Andererseits sind auch Fälle von akuter Fazialisparese unter einer COVID-19-Erkrankung beschrieben, sodass sich die theoretische Frage stellt, inwieweit die Impfung möglicherweise eher das Auftreten einer Fazialisparese verhindert als befördert. Schlussendlich lässt sich die akute Fazialisparese, wenn schnell gehandelt wird, gut therapieren und ist von der Schwere und Folgeerscheinungen nicht mit der Krankheitsschwere und den möglichen Folgeerscheinungen einer COVID-19-Erkrankung zu vergleichen.

show abstract

“…There has been an increase in the number of reports in the literature of rectly linked or just coincidental is still a matter of debate. While some Authors suggest a higher occurrence of facial palsy during the COVID-19 outbreak, tious disorders [71][72][73] .…”

Section: Facial and Vestibulocochlear Nervesmentioning

confidence: 99%